Journal article icon

Journal article

GABA regulates electrical activity and tumor initiation in melanoma

Abstract:

Oncogenes can initiate tumors only in certain cellular contexts, which is referred to as oncogenic competence. In melanoma, whether cells in the microenvironment can endow such competence remains unclear. Using a combination of zebrafish transgenesis coupled with human tissues, we demonstrate that GABAergic signaling between keratinocytes and melanocytes promotes melanoma initiation by BRAFV600E. GABA is synthesized in melanoma cells, which then acts on GABA-A receptors in keratinocytes. Electron microscopy demonstrates specialized cell–cell junctions between keratinocytes and melanoma cells, and multielectrode array analysis shows that GABA acts to inhibit electrical activity in melanoma/keratinocyte cocultures. Genetic and pharmacologic perturbation of GABA synthesis abrogates melanoma initiation in vivo. These data suggest that GABAergic signaling across the skin microenvironment regulates the ability of oncogenes to initiate melanoma.

Significance: This study shows evidence of GABA-mediated regulation of electrical activity between melanoma cells and keratinocytes, providing a new mechanism by which the microenvironment promotes tumor initiation. This provides insights into the role of the skin microenvironment in early melanomas while identifying GABA as a potential therapeutic target in melanoma.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1158/2159-8290.cd-23-0389

Authors


More by this author
Role:
Author
ORCID:
0000-0002-2586-1427
More by this author
Role:
Author
ORCID:
0000-0002-5112-7357
More by this author
Role:
Author
ORCID:
0000-0003-3295-6755
More by this author
Role:
Author
ORCID:
0000-0002-9040-6957
More by this author
Role:
Author
ORCID:
0000-0002-2070-0106


Publisher:
American Association for Cancer Research
Journal:
Cancer Discovery More from this journal
Volume:
13
Issue:
10
Pages:
2270-2291
Publication date:
2023-10-05
Acceptance date:
2023-08-02
DOI:
EISSN:
2159-8290
ISSN:
2159-8274
Pmid:
37553760


Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP